Navigation Links
Quest Diagnostics Increases Share Repurchase Authority by $1 Billion
Date:8/20/2013

MADISON, N.J., Aug. 20, 2013 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors has increased the company's share repurchase authorization by $1 billion, bringing the total authorization to approximately $1.3 billion.

(Logo:  http://photos.prnewswire.com/prnh/20130717/NY48934LOGO)

"The increase in our share repurchase authorization is consistent with our long-term disciplined capital deployment strategy, which includes returning the majority of our free cash flow to shareholders," said Steve Rusckowski, President and CEO. "In addition to our existing capital deployment commitments, we intend to use the approximately $300 million in net proceeds from the recent sale of the ibrutinib royalty rights to repurchase Quest Diagnostics shares as part of our stock buyback program."

About Quest Diagnostics
Quest Diagnostics is the world's leading provider of diagnostic information services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic information services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at QuestDiagnostics.com. Follow us at Facebook.com/QuestDiagnostics and Twitter.com/QuestDX'/>"/>

SOURCE Quest Diagnostics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date
2. Software Pioneer Leaves $10 Million Bequest To Five Leading Non-profits In Health And Drug Policy Reform
3. Quest Diagnostics To Speak At The Wells Fargo Securities 2012 Healthcare Conference
4. Quest Diagnostics to Release Second Quarter 2012 Financial Results on July 19
5. Questcor Pharmaceuticals to Present at JMP Securities Healthcare Conference
6. Questcor to Report Second Quarter Results on July 24, 2012
7. Watson and Actavis Receive FTC Second Request
8. Questcor Reports Second Quarter Financial Results
9. Roper Industries to Acquire Sunquest Information Systems
10. Endpoints - Clinical Trials in Respiratory Diseases - Pulmonary Function Tests, Biomarkers and Quality of Life Questionnaires All Play Prominent Roles
11. Quest Diagnostics Launches Molecular Cervical Cancer Test Based on National Institutes of Healths TERC Gene Marker
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... , May 29, 2015 Educating ... of the Association for the Advancement of Wound ... With support from AAWC,s corporate partners, the ... Portal on the AAWC website at ... wound care pathway with links to various CME/CEU ...
(Date:5/28/2015)... 28, 2015 Research ... addition of Jain PharmaBiotech,s new report  "RNAi ... their offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... silencing involves the use of double stranded ... material is processed into short 21-23 nucleotide ...
(Date:5/28/2015)... The controversy surrounding the use of ... (procedures to remove uterine fibroids) continues, as a ... Johnson & Johnson,s Ethicon, Inc. unit, which was ... to the report published by The Wall Street ... is trying to determine what the company knew ...
Breaking Medicine Technology:The Association for the Advancement of Wound Care Educates the Public 2Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 2Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 3Power Morcellator Attorneys at Bernstein Liebhard LLP Comment on Report That FBI Is Investigating Ethicon Morcellators 2Power Morcellator Attorneys at Bernstein Liebhard LLP Comment on Report That FBI Is Investigating Ethicon Morcellators 3
... , PHILADELPHIA , Jan. 26 ... has licensed LiquentConnect® - a hosted software as ... review, amend and submit regulatory dossiers.  Omnicare Clinical Research is ... serving the biopharmaceutical and medical device industries. , LiquentConnect ...
... WORTH, Texas and PETERBOROUGH, Ontario , Jan. ... marketing Collagenase SANTYL® Ointment to healthcare professionals in Canada ... debriding chronic dermal ulcers (e.g., pressure ulcers, vascular ulcers, and ... only enzymatic debrider available in the Canadian market. , ...
Cached Medicine Technology:Omnicare Clinical Research Licenses LiquentConnect to Create Added Value for Clients 2Omnicare Clinical Research Licenses LiquentConnect to Create Added Value for Clients 3Healthpoint Launches Collagenase SANTYL(R) Ointment in Canada 2Healthpoint Launches Collagenase SANTYL(R) Ointment in Canada 3
(Date:5/29/2015)... 29, 2015 M3 USA MDLinx.com, source ... 14 medical specialties, now offers The Smartest Rheumatologist ... of rheumatology disorders ranging from Fibromyalgia and Osteoporosis, to ... director of MDLinx, and Caroline Tredway, editorial head of ... it will have on the physicians who participate. Says ...
(Date:5/29/2015)... 2015 Abington Hospital – Jefferson ... first hospitals in the nation to join the ... practices and work toward achieving the Baby-Friendly USA© ... focusing on maternity care practices leading to Baby-Friendly ... and Prevention, EMPower is aimed at increasing breastfeeding ...
(Date:5/29/2015)... Dot Hill can mark one more item off her bucket ... Woods retirement community is the oldest woman to have flown ... was great fun!”, she exclaimed. “I’ve always wanted to jump ... they thought this would be ok.” , “We put on nylon ... she described. “I don’t remember it being noisy, but the ...
(Date:5/29/2015)... North Carolina (PRWEB) May 29, 2015 ... confirmed that the newest Red Hot & Blue restaurant at ... business on Thursday, May 7, 2015. “The Red Hot & ... center for 18 years, but we have moved to a ... are now in the middle of all the activities on ...
(Date:5/29/2015)... 2015 Johnson & Johnson and ... Risperdal lawsuit ( http://www.risperdallawsuit2014.com/ ) settlement with a ... his use of the antipsychotic medication. According to ... the third bellwether trial to involve male breast ... in Pennsylvania’s Philadelphia Court of Common Pleas, where ...
Breaking Medicine News(10 mins):Health News:MDLinx Launches Smartest Rheumatologist 2Health News:Abington Hospital Selected to Join Baby-Friendly Hospital Initiative 2Health News:Indoor Skydiving Brings Thrills to Seniors 2Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 2Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 3Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 4Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 3
... Despite the popularity of colon cleansing, there,s no evidence ... or in day spas -- offers any health benefits, a ... side effects ranging from vomiting to kidney failure and death, ... also called colonic irrigation or colonic hydrotherapy -- often involves ...
... WASHINGTON, Aug. 1Researchers at the Massachusetts Institute of Technology ... high-speed, three-dimensional (3-D) imaging of microscopic pre-cancerous changes in ... the Optical Society,s (OSA) open access journal Biomedical ... called optical coherence tomography (OCT), which offers a way ...
... is a mysterious developmental disease because it often leaves ... example, it is well documented that autistic children often ... as "you" instead of "I." A new brain ... by scientists at Carnegie Mellon University provides an explanation ...
... -- A new study seems to confirm the widely held ... e-mails, social media and news. Researchers analyzed the habits ... found that they checked their devices throughout their waking hours. ... opening the screen lock and accessing a single application. ...
... Alexandria, VA - The 2011 Annual Meeting & OTO ... and Neck Surgery Foundation (AAO-HNSF), the largest meeting of ... convene September 11-14, 2011 in San Francisco, CA. ... and several hundred instruction course hours for attendees, the ...
... dietary counseling for obesity are heavily rooted in the ... ability to choose healthy foods and portion sizes consistent ... According to preventive medicine and behavioral ... new counseling approach that views obesity as a result ...
Cached Medicine News:Health News:Colon Cleansing Has No Health Benefit, May Harm: Report 2Health News:New high-speed 3-D imaging system holds potential for improved cancer screening 2Health News:New high-speed 3-D imaging system holds potential for improved cancer screening 3Health News:New high-speed 3-D imaging system holds potential for improved cancer screening 4Health News:New CMU brain imaging research reveals why autistic individuals confuse pronouns 2Health News:New CMU brain imaging research reveals why autistic individuals confuse pronouns 3Health News:Smartphones Really Are Habit-Forming: Study 2Health News:World's largest meeting of ear, nose and throat doctors 2Health News:Obesity counseling should focus on neurobehavioral processes, not personal choice, researchers say 2Health News:Obesity counseling should focus on neurobehavioral processes, not personal choice, researchers say 3
MAXM is a reliable benchtop solution for processing mid-size volume workloads. Features include three-dimensional VCS technology, continuous autoloading and easy-to-use data management capabilities....
... The LH 755 simplifies ... by integrating expert automation and ... It delivers reliable, accurate results ... the best slide quality with ...
Creatinine Test Kit (enzymatic, liquid reagents), Wavelength: 550 nm. Linear range: up to 150 mg/dL....
Kinetic and endpoint methods for the quantitative determination of creatinine in serum....
Medicine Products: